Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Gedatolisib|DRUG: Palbociclib|DRUG: Fulvestrant|DRUG: Alpelisib
Sponsor: Celcuity Inc